About

About PurpleAI PurpleAI is a fast-growing medical AI pioneer transforming stroke care through intelligent automation—enhancing workflow efficiency and diagnostic accuracy to drive better patient outcomes. Building on the proven success of its diagnostic support AI solutions, PurpleAI is now expanding into multi-modal, predictive analytics. Its upcoming flagship SaMD, StrokeShieldAI, is designed to anticipate and monitor high-risk complications following initial stroke treatment. By equipping clinicians with real-time foresight, StrokeShieldAI enables earlier intervention, mitigates adverse outcomes, and sets a new standard for stroke care. Founded as an independent company in October 2024 (after operating within SK Group since 2019), PurpleAI is a fast-growing medical AI innovator transforming stroke care through intelligent automation and predictive insight—enhancing workflow efficiency, diagnostic accuracy, and patient outcomes. PurpleAI is expanding its Hyper Insight™ portfolio across multiple imaging modalities and advancing into multi-modal, data-driven predictive analytics. Its upcoming flagship, StrokeShieldAI, is built to anticipate and monitor high-risk complications after initial stroke treatment—providing clinicians with real-time foresight for earlier intervention and better outcomes.